Miller Fisher Syndrome disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Miller Fisher Syndrome

MalaCards integrated aliases for Miller Fisher Syndrome:

Name: Miller Fisher Syndrome ¹¹ ⁵² ⁵⁸ ⁷⁵ ⁵³ ⁴³ ¹⁴ ¹⁶ ⁷¹

Cranial Variant of Gbs ¹⁹ ⁵⁸

Miller-Fisher Variant of Guillain-Barre Syndrome ¹¹

Cranial Variant of Guillain-Barré Syndrome ¹⁹

Cranial Variant of Guillain-Barre Syndrome ⁵⁸

Miller-Fisher Syndrome ¹⁹

Fisher's Syndrome ¹¹

Fisher Syndrome ⁵⁸

Characteristics:

Inheritance:

Multigenic/multifactorial ⁵⁸

Prevelance:

1-9/1000000 (Europe) ⁵⁸

Age Of Onset:

All ages ⁵⁸

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Neuronal diseases Immune diseases

See all MalaCards categories (disease lists)

ICD10: ³¹ ³²

Diseases of the nervous system

Polyneuropathies and other disorders of the peripheral nervous system

Inflammatory polyneuropathy

Guillain-Barré syndrome

Orphanet: ⁵⁸

Rare neurological diseases

External Ids:

Disease Ontology ¹¹ DOID:12889

MeSH ⁴³ D019846

NCIt ⁴⁹ C116958

SNOMED-CT ⁶⁸ 1767005

ICD10 ³¹ G61.0

MESH via Orphanet ⁴⁴ D019846

ICD10 via Orphanet ³² G61.0

UMLS via Orphanet ⁷² C0393799

Orphanet ⁵⁸ ORPHA98919

EFO ¹⁶ EFO_0007371

UMLS ⁷¹ C0393799

Sources

Summaries for Miller Fisher Syndrome

GARD: ¹⁹ Miller Fisher syndrome is a rare acquired nerve disease considered to be a variant of Guillain-Barré syndrome. The main features are lack of muscle coordination (ataxia), eye muscle weakness resulting in the inability to move the eyes in several directions (ophthalmoplegia), and the absence of tendon reflexes. Symptoms often start several days after a viral illness. Other symptoms include generalized muscle weakness and respiratory failure. The cause is not known, but it is thought to be an autoimmune disease in which there are autoantibodies that attack the nerves. In most people with Miller Fisher syndrome an antibody (anti-GQ1b) is identified. The presence of these autoantibodies helps confirm the diagnosis of the syndrome.

MalaCards based summary: Miller Fisher Syndrome, also known as cranial variant of gbs, is related to guillain-barre syndrome and severe acute respiratory syndrome, and has symptoms including ophthalmoplegia and cerebellar ataxia. An important gene associated with Miller Fisher Syndrome is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Spinal cord injury and Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway. The drugs Sodium citrate and Citric acid have been mentioned in the context of this disorder. Affiliated tissues include eye, heart and dorsal root ganglion, and related phenotypes are nervous system and growth/size/body region

NINDS: ⁵² Miller Fisher syndrome is a rare, acquired nerve disease that is considered to be a variant of Guillain-Barré syndrome. It is characterized by abnormal muscle coordination, paralysis of the eye muscles, and absence of the tendon reflexes. Like Guillain-Barré syndrome, symptoms may be preceded by a viral illness. Additional symptoms include generalized muscle weakness and respiratory failure. The majority of individuals with Miller Fisher syndrome have a unique antibody that characterizes the disorder.

Disease Ontology: ¹¹ A Guillain-Barre syndrome that manifests as a descending paralysis. It usually affects the eye muscles first and presents with the triad of ophthalmoplegia, ataxia, and areflexia.

Orphanet: ⁵⁸ Miller-Fisher syndrome (MFS) is a rare cranial nerve variant of Guillain-Barré syndrome (GBS; see this term).

Wikipedia: ⁷⁵ Guillain-Barré syndrome (GBS) is a rapid-onset muscle weakness caused by the immune system damaging the... more...

Sources

Related Diseases for Miller Fisher Syndrome

Diseases related to Miller Fisher Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 598)

#	Related Disease	Score	Top Affiliating Genes
1	guillain-barre syndrome	32.7	TNF MOG ALB
2	severe acute respiratory syndrome	30.8	TNF TMPRSS2 IL6 ACE2
3	polyneuropathy	30.8	NFASC MAG CNTN1 ALB
4	viral infectious disease	30.8	TNF IL6 CCR6 ACE2
5	covid-19	30.8	TNF TMPRSS2 IL6 CCR6 ACE2
6	bell's palsy	30.7	TNF IL6 ALB ACE2
7	abducens palsy	30.7	MUSK MOG AQP4
8	chronic inflammatory demyelinating polyradiculoneuropathy	30.5	NFASC MUSK MAG CNTN1
9	autoimmune peripheral neuropathy	30.4	NFASC MAG CNTN1
10	pharyngitis	30.3	TNF IL6 CCR6
11	neuritis	30.3	TNF MOG MAG IL6 AQP4
12	adult-onset still's disease	30.3	TNF IL6 CCR6
13	optic neuritis	30.2	TNF MOG MAG IL6 AQP4
14	human cytomegalovirus infection	30.2	TNF IL6 CCR6
15	common cold	30.2	TNF TMPRSS2 IL6 CCR6 ACE2
16	autoimmune neuropathy	30.1	NFASC MAG LGI1 CNTNAP2 CNTN1
17	dengue disease	30.1	TNF IL6 CCR6 ALB
18	juvenile rheumatoid arthritis	30.1	TNF IL6 CCR6
19	gastroenteritis	30.0	TNF IL6 ALB
20	internuclear ophthalmoplegia	30.0	PNMA2 MUSK MOG AQP4
21	facial paralysis	30.0	TNF MOG IL6 AQP4 ALB ACE2
22	lambert-eaton myasthenic syndrome	30.0	TNF MUSK AMPH
23	wernicke encephalopathy	29.9	PNMA2 AQP4 ALB
24	neuromuscular disease	29.9	MUSK MAG AMPH ALB
25	neuromyelitis optica	29.9	MOG IL6 AQP4
26	autonomic nervous system disease	29.8	TNF IL6 ALB
27	appendicitis	29.8	TNF IL6 ALB
28	intestinal obstruction	29.8	TNF IL6 ALB
29	meningitis	29.8	TNF IL6 AQP4 ALB
30	intracranial hypertension	29.8	TNF IL6 AQP4 ALB
31	pneumonia	29.7	TNF IL6 ALB ACE2
32	demyelinating disease	29.7	TNF MOG MAG IL6 CCR6 AQP4
33	papilledema	29.7	MOG IL6 AQP4 ALB
34	exanthem	29.7	TNF IL6 CCR6 ALB
35	urinary tract infection	29.7	TNF IL6 CCR6 ALB
36	typhoid fever	29.7	TNF IL6 CCR6 ALB
37	respiratory failure	29.7	TNF TMPRSS2 MUSK IL6 CCR6 ALB
38	monoclonal gammopathy of uncertain significance	29.7	MAG IL6 CCR6 ALB
39	crohn's disease	29.7	TNF IL6 CCR6 ALB
40	aseptic meningitis	29.7	TNF MOG IL6 ALB
41	movement disease	29.6	LGI1 GAD2 CNTNAP2 AMPH
42	cerebrovascular disease	29.6	TNF IL6 CCR6 ALB
43	rheumatic fever	29.6	TNF IL6 ALB
44	encephalitis	29.6	TNF PNMA2 MOG LGI1 IL6 CNTNAP2
45	stroke, ischemic	29.6	TNF IL6 AQP4 ALB ACE2
46	cranial nerve palsy	29.5	TNF MOG AQP4 ALB
47	brachial plexus neuritis	29.5	NFASC MUSK MOG LGI1 AQP4
48	uremia	29.5	TNF IL6 ALB
49	inappropriate adh syndrome	29.5	LGI1 IL6 AQP4 ALB
50	coronavirus infectious disease	29.3	TNF TMPRSS2 IL6 CCR6 ALB ACE2

Graphical network of the top 20 diseases related to Miller Fisher Syndrome:

Sources

Symptoms & Phenotypes for Miller Fisher Syndrome

UMLS symptoms related to Miller Fisher Syndrome:

ophthalmoplegia; cerebellar ataxia

MGI Mouse Phenotypes related to Miller Fisher Syndrome:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	nervous system	MP:0003631	10.17	AMPH AQP4 CCR6 CNTN1 CNTNAP2 GAD2
2	growth/size/body region	MP:0005378	9.97	ACE2 AQP4 CNTN1 CNTNAP2 GAD2 IL6
3	muscle	MP:0005369	9.96	ACE2 ALB CNTN1 GAD2 IL6 MOG
4	behavior/neurological	MP:0005386	9.83	AMPH AQP4 CNTN1 CNTNAP2 GAD2 IL6
5	respiratory system	MP:0005388	9.23	ACE2 AQP4 GAD2 IL6 MUSK SRF

Sources

Drugs & Therapeutics for Miller Fisher Syndrome

Drugs for Miller Fisher Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Sodium citrate

Approved, Investigational

68-04-2

23431961

2

Citric acid

Approved, Nutraceutical, Vet_approved

77-92-9

311

3

Pharmaceutical Solutions

4

Hemostatics

5

Citrate

6

Immunoglobulins, Intravenous

7

Immunoglobulins

8

Antibodies

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	A Prospective Interventional Study to Investigate Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation With or Without Coagulation Factors Replacement	Unknown status	NCT03801135		Fibrinogen concentrate
2	International GBS Outcome Study (IGOS): A Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).	Active, not recruiting	NCT01582763

Search NIH Clinical Center for Miller Fisher Syndrome

Cochrane evidence based reviews: miller fisher syndrome

Sources

Genetic Tests for Miller Fisher Syndrome

Sources

Anatomical Context for Miller Fisher Syndrome

Organs/tissues related to Miller Fisher Syndrome:

MalaCards : Eye, Heart, Dorsal Root Ganglion, Brain, Cerebellum, T Cells, Lung

Sources

Publications for Miller Fisher Syndrome

Articles related to Miller Fisher Syndrome:

(show top 50) (show all 1271)

#	Title	Authors	PMID	Year
1	Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. ⁵³ ⁶²	Buchwald B...Dudel J	9753137	1998
2	Antibodies to Glycolipids in Guillain-Barré Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases. ⁶²	Kusunoki S	36255685	2023
3	A case of COVID-19 with multiple cranial neuropathies. ⁶²	Gogia B...Fang X	33372575	2022
4	Neurological manifestations of COVID-19: a retrospective observational study based on 1060 patients with a narrative review. ⁶²	Negro A...d'Agostino V	36451533	2022
5	Miller-Fisher syndrome after first dose of Oxford/AstraZeneca coronavirus disease 2019 vaccine: a case report. ⁶²	Pirola FJC...de Aguiar PHP	36384584	2022
6	A teenager with ophthalmoparesis and dysphagia. ⁶²	Tayade K...Elavarasi A	36427894	2022
7	Efferent neuro-ophthalmic complications of coronavirus disease 2019. ⁶²	Dinkin M...Sathi S	36165417	2022
8	Miller Fisher syndrome after Pfizer BioNTech vaccine booster responsive to intravenous Ig treatment. ⁶²	Chen B...Eggenberger E	36357112	2022
9	Guillain-Barré syndrome from an emergency department view: how to better predict the outcome? ⁶²	Covino M...Luigetti M	35580194	2022
10	Miller Fisher syndrome following COVID-19 vaccines: A scoping review. ⁶²	Kim JE...Bae JS	35938305	2022
11	Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review. ⁶²	Putry BO...Pasiak TF	36338884	2022
12	Guillain-Barré syndrome in children - High occurrence of Miller Fisher syndrome in East Asian region. ⁶²	Chiu ATG...Chan SHS	35906115	2022
13	Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology. ⁶²	Stein RA	36137262	2022
14	Course and Treatment of a Rare Neurological Sequelae After COVID-19: Miller Fisher Syndrome. ⁶²	Kara S...Nedd K	36381748	2022
15	Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review. ⁶²	Liang H...Chen H	36315834	2022
16	Positive anti-GQ1b Miller Fisher syndrome and Escherichia coli infection: A case report. ⁶²	Bejarano-Ferreyra JH...Flores-Mendoza M	36195377	2022
17	Miller Fisher syndrome complicated by inappropriate secretion of antidiuretic hormone: a case report. ⁶²	Benkirane A...London F	35871211	2022
18	A rare overlap between Miller Fisher syndrome and pure motor Guillain-Barre syndrome. ⁶²	Boutros N...Trikamji B	36201115	2022
19	Emphasis on the Optimal Functional Recovery Through a Structured Inpatient Rehabilitation Program Along With a Home Exercise Regime in an Individual With Miller-Fisher Syndrome: A Case Report. ⁶²	Boob MA...Salphale VG	36348871	2022
20	Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody. ⁶²	Shoraka AR...Li X	33280463	2022
21	Paralytic ileus as first symptom of Miller Fisher syndrome: A case report. ⁶²	Liu X...Zhang X	36086690	2022
22	Acute Isolated External Ophthalmoplegia: Think of Anti-GQ1b Antibody Syndrome. ⁶²	Badal S...Gulati S	36352629	2022
23	A Rare Presentation of a Complex Mixed Autoimmune Encephalitis Diagnosis: A Case Report and Literature Review. ⁶²	Khunkhun S...Tamton H	36321035	2022
24	[Miller Fisher syndrome]. ⁶²	Andreasen AM...Guzman-Martin A	36205161	2022
25	Cardiovascular Autonomic Assessment in Guillain-Barré Syndrome: A Longitudinal Study. ⁶²	Tan CY...Tan MP	36352579	2022
26	Treatable Ataxias: How to Find the Needle in the Haystack? ⁶²	Stezin A...Pal PK	36065614	2022
27	Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database. ⁶²	Kim JE...Song TJ	35751472	2022
28	Guillain-barré syndrome without limb weakness: A rare variant with acute bulbar palsy. ⁶²	Chavada IJ...Natarajan V	36353017	2022
29	Weakness in both lower limbs for 1 week and blepharoptosis for 3 days in a boy aged 1 year and 7 months. ⁶²	Lang CH...Shu XM	36036132	2022
30	Clinical Reasoning: An 8-Year-Old With Acute Onset Ataxia. ⁶²	McLaren JR...Staley KJ	35970580	2022
31	A case of Miller Fisher syndrome with delayed onset peripheral facial nerve palsy after COVID-19 vaccination: a case report. ⁶²	Nanatsue K...Inaba A	35996074	2022
32	Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges. ⁶²	Hadjivassiliou M...Mitoma H	36138901	2022
33	Severe Vision Loss and Optic Disc Edema Associated With GAD-65 Antibody Positive Miller Fisher Syndrome. ⁶²	Yasin A...Jiang H	36000786	2022
34	Miller Fisher syndrome associated with COVID 19. ⁶²	Yaqoob A...Wani F	36387653	2022
35	Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies. ⁶²	Murakami K...Ito H	35537332	2022
36	Miller-Fisher syndrome associated with SARS-CoV-2: a case report. ⁶²	Faulkner L...Flint N	35240290	2022
37	COVID-19 Presenting As Miller Fisher Syndrome in a Patient With a History of Guillain-Barré Syndrome: A Case Report. ⁶²	Aldabain L...Alissa M	35936171	2022
38	[Pathophysiological and diagnostic aspects of Guillain-Barré syndrome]. ⁶²	Carpentier VT...Weiss N	34998626	2022
39	Are Miller Fisher syndrome and CANDA due to a paranodopathy? ⁶²	Vallat JM...Mathis S	35576641	2022
40	Neuroimmune disorders in COVID-19. ⁶²	Arino H...Vogrig A	35353232	2022
41	Serum thyroid-stimulating hormone is an independent risk factor of recurrent Guillain-Barré syndrome. ⁶²	Wang S...Peng T	35342963	2022
42	SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology? ⁶²	Guilmot A...Gille M	34476752	2022
43	Recurrent Miller Fisher Syndrome. ⁶²	Ooi ST...Yaakub A	35891880	2022
44	Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China. ⁶²	Liu M...Guan H	35618871	2022
45	Miller Fisher syndrome after COVID-19 vaccination: Case report and review of literature. ⁶²	Siddiqi AR...Yousaf Z	35608434	2022
46	Modified Zipper Method, a Promising Treatment Option in Severe Pediatric Immune-Mediated Neurologic Disorders. ⁶²	Nikolaus M...Kaindl AM	35435761	2022
47	COVID-19-Associated Miller Fisher Syndrome With Long Latency Period: A Case Report. ⁶²	Kuang W...Jayasekara D	35663687	2022
48	Costs of Guillain-Barré Syndrome in the Brazilian Federal District: the patients' perspective. ⁶²	Oliveira AFM...Peixoto HM	34358316	2022
49	Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome. ⁶²	Singh J...Dinkar A	35507796	2022
50	When your cat takes you to the ICU: Miller Fisher/ Guillain-Barré-overlap-syndrome caused by Pasteurella multocida infection resembling wound botulism. ⁶²	Moller L...Simon OJ	35123165	2022

Sources

Genes for Miller Fisher Syndrome

Genes related to Miller Fisher Syndrome (0 elite genes):

(show all 19)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	TNF	Tumor Necrosis Factor	Protein Coding	13.48	DISEASES inferred ¹⁴ GeneCards inferred via : Publications (show sections)
2	SRF	Serum Response Factor	Protein Coding	11.38	Novoseek inferred ⁵³ GeneCards inferred via : Publications (show sections)	9753137
3	ACE2	Angiotensin Converting Enzyme 2	Protein Coding	6.76	DISEASES inferred ¹⁴
4	MAG	Myelin Associated Glycoprotein	Protein Coding	6.26	DISEASES inferred ¹⁴
5	CCR6	C-C Motif Chemokine Receptor 6	Protein Coding	6.22	DISEASES inferred ¹⁴ ¹⁴
6	NFASC	Neurofascin	Protein Coding	6.14	DISEASES inferred ¹⁴
7	RNF112	Ring Finger Protein 112	Protein Coding	5.83	DISEASES inferred ¹⁴
8	MUSK	Muscle Associated Receptor Tyrosine Kinase	Protein Coding	5.79	DISEASES inferred ¹⁴
9	MOG	Myelin Oligodendrocyte Glycoprotein	Protein Coding	5.75	DISEASES inferred ¹⁴
10	CNTNAP2	Contactin Associated Protein 2	Protein Coding	5.72	DISEASES inferred ¹⁴
11	TMPRSS2	Transmembrane Serine Protease 2	Protein Coding	5.67	DISEASES inferred ¹⁴
12	CNTN1	Contactin 1	Protein Coding	5.64	DISEASES inferred ¹⁴
13	AMPH	Amphiphysin	Protein Coding	5.6	DISEASES inferred ¹⁴
14	PNMA2	PNMA Family Member 2	Protein Coding	5.59	DISEASES inferred ¹⁴
15	IL6	Interleukin 6	Protein Coding	5.56	DISEASES inferred ¹⁴
16	GAD2	Glutamate Decarboxylase 2	Protein Coding	5.55	DISEASES inferred ¹⁴
17	AQP4	Aquaporin 4	Protein Coding	5.5	DISEASES inferred ¹⁴
18	ALB	Albumin	Protein Coding	5.44	DISEASES inferred ¹⁴
19	LGI1	Leucine Rich Glioma Inactivated 1	Protein Coding	5.42	DISEASES inferred ¹⁴

Sources

Variations for Miller Fisher Syndrome

Sources

Expression for Miller Fisher Syndrome

Search GEO for disease gene expression data for Miller Fisher Syndrome.

Sources

Pathways for Miller Fisher Syndrome

Pathways related to Miller Fisher Syndrome according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Spinal cord injury ⁷⁴	11.52	TNF MAG IL6 AQP4
2	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway ⁷⁴	10.91	TNF IL6 ACE2
3	Oligodendrocyte specification and differentiation, leading to myelin components for CNS ⁷⁴	10.58	TNF MOG MAG
4	SARS-CoV-2 and COVID-19 pathway ⁷⁴	10.37	TMPRSS2 ACE2
5	Cells and molecules involved in local acute inflammatory response ⁷⁴ Show member pathways IL8-mediated signaling events ⁶¹	10.02	TNF IL6
6	COVID-19 adverse outcome pathway ⁷⁴	9.8	TMPRSS2 IL6 ACE2

Sources

GO Terms for Miller Fisher Syndrome

Cellular components related to Miller Fisher Syndrome according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	plasma membrane	GO:0005886	9.64	TNF TMPRSS2 NFASC MUSK MAG CCR6
2	plasma membrane	GO:0005887	9.64	TNF TMPRSS2 NFASC MUSK MAG CCR6

Biological processes related to Miller Fisher Syndrome according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	positive regulation of gap junction assembly	GO:1903598	9.67	CNTNAP2 ACE2
2	vascular endothelial growth factor production	GO:0010573	9.62	TNF IL6
3	central nervous system myelin formation	GO:0032289	9.56	MAG CNTN1
4	regulation of vascular endothelial growth factor production	GO:0010574	9.46	IL6 AQP4
5	transmission of nerve impulse	GO:0019226	9.43	NFASC MAG CNTNAP2
6	neuron projection development	GO:0031175	9.23	SRF LGI1 IL6 CNTNAP2 CNTN1

Sources

Sources for Miller Fisher Syndrome

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: MLL002 MIFTS: 45	Miller Fisher Syndrome Categories: Immune diseases, Neuronal diseases, Rare diseases	Data Licensing For inquiries, contact: [email protected]
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs Expand all tables